0002066303-25-000001.txt : 20250501 0002066303-25-000001.hdr.sgml : 20250501 20250501113419 ACCESSION NUMBER: 0002066303-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 EFFECTIVENESS DATE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mivax Therapeutics, Inc. CENTRAL INDEX KEY: 0002066303 ORGANIZATION NAME: EIN: 990726699 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544963 FILM NUMBER: 25900739 BUSINESS ADDRESS: STREET 1: 701 CHINA BASIN ST STREET 2: APT 605 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 7857706160 MAIL ADDRESS: STREET 1: 701 CHINA BASIN ST STREET 2: APT 605 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0002066303 Mivax Therapeutics, Inc. 701 China Basin St Apt 605 San Francisco CA CALIFORNIA 94158 7857706160 DELAWARE None None Corporation true 2024 Viraj Balkrishna Deshpande 701 China Basin St Apt 605 San Francisco CA CALIFORNIA 94158 Executive Officer President and Secretary Pragyesh Dhungel 556 Wisconsin St San Francisco CA CALIFORNIA 94107 Executive Officer Chief Executive Officer and Treasurer Biotechnology No Revenues 06b false 2025-04-17 false true false 2000 Indefinite 107500 Indefinite Some or all of non-U.S. investors were offered securities under Reg S and are excluded from Reg D reporting. true 7 15 0 0 0 false Mivax Therapeutics, Inc. Viraj Balkrishna Deshpande Viraj Balkrishna Deshpande President 2025-05-01